Liquidia Corporation has announced the appointment of Dana Boyle as the new Chief Accounting Officer, effective July 1, 2025. Previously, Boyle held the position of Senior Vice President, Finance and Controller at the company. Her past experience includes serving as Controller for Aerami Therapeutics, Inc., and Director of Financial Planning and Analysis at Aralez Pharmaceuticals Inc. Boyle began her career as an auditor at Deloitte & Touche LLP and holds a Bachelor of Science in accounting from Rutgers University.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.